[Case Report] Stress induced (Takotsubo) cardiomyopathy triggered by the COVID-19 pandemic. by Giannitsi, S et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE  20: 2812-2814,  20202812
Abstract. Stress induced (Takotsubo) cardiomyopathy 
(TC) represents an acute heart failure syndrome triggered 
by physical or emotional stressors. COVID-19 pandemic 
has caused an unprecedented health crisis resulting in fear, 
distress and anxiety, with emerging cardiovascular implica-
tions. COVID-19 related stress can act as potential trigger for 
TC. We present a case of an elderly female who developed TC 
due to stress surrounding COVID-19.
Case presentation
A 79-year old female presented with acute chest pain after 
watching the daily TV report on the death toll of COVID-19 
pandemic. Her medical history included arterial hypertension 
under treatment with ace-inhibitors. She was haemody-
namically stable, with a blood pressure of 130/70 mmHg, a 
heart rate of 75 beats/min in sinus rhythm, and an oxygen 
saturation of 99% in room air. Physical examination and 
body temperature were normal. Electrocardiogram recorded 
diffuse ST segment elevation (Fig. 1A). Emergency coro-
nary angiography excluded stenotic lesions (Fig. 1B and C). 
Left ventriculography illustrated severe hypokinesia in 
the mid-apical segments, hyperdynamic basal segments 
(Fig. 1D, systole; and E, diastole), and impaired left ventric-
ular systolic function with an ejection fraction of 35%. High 
sensitive troponine-T was elevated reaching a peak after 12 h 
(2.950 pg/ml, normal <15.6 pg/ml), whereas other routine 
blood tests, including inflammatory markers, were normal.
The diagnosis
Stress induced (Takotsubo) cardiomyopathy.
Discussion
Takotsubo cardiomyopathy (TC), also called stress-induced 
cardiomyopathy, mimics an acute coronary syndrome (ACS), 
predominantly affecting elderly women and is triggered by an 
emotional or physical stressor (1), in our case the COVID-19 
death update. The term ‘Takotsubo’ means ‘octopus pot’ in 
Japanese and describes the pathognomonic left ventricular 
end-systolic apical ballooning, illustrated in transthoracic 
echocardiogram (TTE) and left ventriculography during 
cononary angiography (1).
Clinical presentation, electrocardiographic findings, and 
biomarker profiles are similar to those of an ACS (2). TC 
represents an acute heart failure syndrome with substantial 
morbidity and mortality (2). The in-hospital and one-year 
mortality of TC has been reported 1-5 and 5.6%, respectively, 
with a recurrence rate of ≤5% (1,2). Left ventricular 
systolic function usually recovers within four weeks (1). 
TC is characterized by a low‑grade chronic inflammatory 
state consisting of myocardial macrophage inflammatory 
infiltrates, substantial increase in the pro-inflammatory, 
classical monocyte subset CD14++CD16-, and an increase 
in the systemic pro-inflammatory cytokines interleukin-6 
(IL-6), IL-8 and chemocine CXCL1 (3). This localized and 
systemic inflammatory response plays a pivotal role in the 
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development of TC, while it might also serve as a promising 
therapeutic target for which no effective treatment currently 
exists (3).
Τhe brain‑heart interaction has been acknowledged as a 
significant factor in the pathogenesis of TC. Overstimulation of 
the sympathetic nervous system is hypothesized as the under-
lying mechanism (2,4). The hypothalamic-pituitary-adrenal 
axis (HPA-axis) is a major neuroendocrine system which 
regulates the release of cortisol from the adrenal gland, 
shifting the metabolism to higher stress levels. Higher serum 
cortisol levels and increased sympathetic activity may cause 
myocardial damage (5). Consequently, acute psychological 
or physical stress mediated via the sympathetic-adrenal- 
medulla axis with catecholamine release in the adrenal 
medulla and the HPA axis with consecutive cortisol release 
from the adrenal cortex may act as a trigger for TC (5). 
Additionally, regional differences in myocardial expression 
of β2-adrenergic receptor density have been shown, which 
mediate the cellular effects of the increased catecholamine 
blood concentrations and explain the regional left ventricular 
myocardial stunning (5).
Therefore, the enormous psychological strain posed on 
the community by the pandemic can activate the brain-heart 
axis and serve as a potential stressor for TC (4,6). COVID-19 
pandemic has caused an unprecedented health crisis resulting 
in individual and societal fear and anxiety, with emerging 
cardiovascular implications, which we should be aware of (4).
The patient was transferred to the coronary unit where 
treatment with ace-inhibitor, aspirin, b-blocker and statin was 
initiated. Her course was uncomplicated with gradual normal-
ization of troponin. She was discharged after one week in good 
condition and normal echocardiography, and was advised to 
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Figure 1. Electrocardiogram showing diffuse ST segment elevation (A). Emergency coronary angiography excluded stenotic lesions  (B and C). Left ventricu-
lography illustrating severe hypokinesia in the mid-apical segments and hyperdynamic basal segments (D, systole; E, diastole).
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